China's NMPA clears initiation of clinical trials with ESG-401 for solid tumors July 23, 2021 No Comments
Antengene obtains HREC approval in Australia for phase I study of ATG-101 in solid tumors and NHL July 22, 2021 No Comments
Kymera Therapeutics STAT3 degradation inducers demonstrate preclinical activity July 20, 2021 No Comments
Phase II/III trial studies SHR-1701 with BP-102 and XELOX in first-line metastatic colorectal cancer July 19, 2021 No Comments
FDA clears IND for phase I trial of SYSA-1801 in advanced pancreatic cancer July 19, 2021 No Comments
HER2 CAR-NK cells show preclinical antitumor activity without off-target cytotoxicity July 19, 2021 No Comments
RSS